July 24, 2013

Repurposing Drugs for an Alzheimer's Treatment? -Dr. Steven Arnold

Thumbnail

Repurposing Drugs for an Alzheimer's Treatment? -Dr. Steven Arnold

About This Episode

A discussion with Dr. Steven Arnold, Professor of Psychiatry and Neurology, University of Pennsylvania and Director of the Penn Memory Center and Dr. Gary Landreth, Professor of Neurosciences and Neurology and Director, Alzheimer's Research Laboratory, Case Western Reserve University School of Medicine. Dr. Arnold is conducting research into drug repurposing with a diabetes drug and Dr. Landreth is researching alternate uses for an existing cancer drug. They were introduced by Dr. Guy Eakin of BrightFocus Foundation, which funds some of this research.

This call was made possible by the generous support of the Emmanuel J. Friedman Philanthropies.

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW